How are IoT experts revolutionizing diabetes-therapy?
30 Nov 2018 10 min read
Consumerization of care and proliferation of ‘digital health’ including wearables, connected health technologies and internet of health, is growing by the day and shaping the future of the healthcare industry in general and life sciences in particular.
Nagarro helps organizations develop a ‘digital and analytics’ driven ecosystem to improve engagement with patients, caregivers and providers through a proactive omni-channel approach.
Consumerization of care and proliferation of ‘digital health’ including wearables, connected health technologies and internet of health, is growing by the day and shaping the future of the healthcare industry in general and life sciences in particular.
Nagarro helps organizations develop a ‘digital and analytics’ driven ecosystem to improve engagement with patients, caregivers and providers through a proactive omni-channel approach.
Regulators, payers, patients and their caregivers are holding life sciences organizations accountable to demonstrate ‘value’ in the real world, beyond RCTs.
Nagarro, with its deep experience in real-world evidence based research, health economics, and outcome based research studies, helps life sciences organizations adapt and lead the path towards value-based care across both ‘R&D’ and ‘Commercial’ parts of the organization.
Regulators, payers, patients and their caregivers are holding life sciences organizations accountable to demonstrate ‘value’ in the real world, beyond RCTs.
Nagarro, with its deep experience in real-world evidence based research, health economics, and outcome based research studies, helps life sciences organizations adapt and lead the path towards value-based care across both ‘R&D’ and ‘Commercial’ parts of the organization.
Clinical trials are long and expensive. Their timely success is imperative for the long-term growth of a life sciences organization.
Nagarro leverages machine learning, big data analytics and advanced cognitive computing capabilities to derive disease and treatment pathway insights and identify the compounds most likely to be successful at an early stage.
.jpg?width=481&height=300&name=shutterstock_250982071%20(1).jpg)
Clinical trials are long and expensive. Their timely success is imperative for the long-term growth of a life sciences organization.
Nagarro leverages machine learning, big data analytics and advanced cognitive computing capabilities to derive disease and treatment pathway insights and identify the compounds most likely to be successful at an early stage.
